3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
11
Gastrointestinal
5
Genitourinary
3
Thoracic
2
Lymphoid
2
Head & Neck
2
Sarcoma
1
Plasma cell
1
Other hematologic neoplasm
1
Other
1
Gynecologic
1
Dermatologic
1
CNS
1
Conditions
Sarcoma
189
Osteosarcoma
72
Sarcoma, Ewing
49
Rhabdomyosarcoma
44
Melanoma
40
Neuroblastoma
35
Gastrointestinal Stromal Tumors
34
Neoplasms
32
Colorectal Neoplasms
29
Glioblastoma
28
Bone Neoplasms
27
Neoplasm Metastasis
26
Ovarian Neoplasms
25
Breast Neoplasms
25
Wilms Tumor
22
Gliosarcoma
22
Glioma
22
Rhabdoid Tumor
21
Lymphoma, Non-Hodgkin
21
Sarcoma, Kaposi
20
Liposarcoma
20
Carcinoma, Non-Small-Cell Lung
20
Pancreatic Neoplasms
18
Neurofibrosarcoma
18
Medulloblastoma
18
Hepatoblastoma
18
Carcinoma, Renal Cell
18
Lymphoma
17
Thyroid Neoplasms
16
Desmoid Tumors
16
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Depression
×
Sarcoma
×
90 days
×
Clear all
NCT06502483
2026-04-21
PRISM
Dana-Farber Cancer Institute
Phase NA
Completed
13 enrolled